Sericin Market

Sericin Market Overview (2025 to 2035)

The global sericin market is expected to be valued at USD 361.5 million in 2025. According to Fact.MR analysis, the industry will be growing at a rate of 5.8% CAGR and have a value of USD 638.9 million in 2035.

Global demand for sericin saw disciplined but significant activities in 2024. Growth in demand for sustainable personal care ingredients, per Fact.MR analysis paved the way for strategic partnerships among raw silk manufacturers from Asia and personal care industry players in Europe.

Specifically, high-end skincare producers steadily used these products toward sustainability goals stipulated by increasingly stringent European Union regulations. Biomedical research progressed further in 2024 through additional clinical trials examining the possibilities of this product in wound healing and tissue engineering. Scale-up difficulties, though, limited supply chains modestly through the moderate pressures felt for prices everywhere.

With the industry entering 2025, Fact.MR opines that manufacturers of this industry stand to gain the most from increasing consumer demand for natural, multifunctional ingredients. Increased product innovations, particularly in regenerative medicine and high-end cosmetic applications, will be driving steady revenue expansion up to 2035.

Increased investment in biotechnology in North America and East Asia for biomaterials made from sericin is also seen to drive long-term industrial growth. Future studies of its antioxidant and anti-inflammatory activities will further solidify its place in nutraceuticals and pharmaceuticals, which will guarantee expansion opportunities in the next decade.

Key Metrics

Metric	Value
Industry Size (2025E)	USD 361.5 million
Industry Value (2035F)	USD 638.9 million
CAGR (2025 to 2035)	5.8%

Fact.MR Survey Results on Sericin Industry Dynamics Based on Stakeholder Perspectives

A FactMR Q4 2024 survey of 500 industry stakeholders in the U.S., Western Europe, Japan, and South Korea recognized overlapping yet distinct trends that rule the global industry. Regionally, 79% of stakeholders stressed demand for sustainable sourcing, and 65% demanded improved bioactive extraction procedures to optimize purity and functional performance.

Among American stakeholders, they preferred products made of this, clean-label skincare, and biomedically compatible, with 61% strongly demanding products that apply biotechnology. Western Europe was leading the regulation-compliant and eco-certified trend in sericin products, with 83% of the respondents listing REACH and COSMOS compliance as conditions. Conversely, 54% of Japanese and South Korean consumers were price-sensitive and stressed the convenience of integrating it into multi-functional propositions. In contrast, only 27% showed an urgent value for higher-priced innovations.

Preferential materials also differed by region. Driven by the silk, the global industry leader (71%) remained, but lightweight hybrid protein mixtures became even more favored in Japan and South Korea. Rising production costs posed a global challenge, accounting for 85%, but the tolerance to price changes varied; Western Europe was better able to withstand the sustainable prices of luxury goods, while Asian economies were more resilient to lower prices. Most regulatory pressure happened in European industries, with very little interference present in East Asia.

Government Regulations

Countries	Government Policy Impact and Certifications
United States	The FDA controls sericin for biomedical applications under biomaterial regulations; cosmetic use has to be in accordance with the FDA's Voluntary Cosmetic Registration Program (VCRP). Clean-label standards are increasing under the FTC Green Guides.
India	The production is tied to the Ministry of Textiles' policies that encourage silk production; firms have to follow BIS (Bureau of Indian Standards) certification for cosmetic-grade sericin.
China	Sericin is subject to China's strict cosmetic regulation, CSAR (Cosmetic Supervision and Administration Regulation) and CFDA (China Food and Drug Administration) mandatory registration for biomedical uses.
United Kingdom	After Brexit, UK REACH governs sericin cosmetic ingredients; cosmetic products must meet UK Cosmetics Regulation 1223/2009.
Germany	EU REACH mandatory compliance with chemical safety standards and COSMOS/ECOCERT certifications for organic sericin ingredients.
South Korea	MFDS (Ministry of Food and Drug Safety) requires registration for sericin-based biomedical products; sericin for cosmetics is subject to KFDA natural material requirements.
Japan	Sericin falls under quasi-drugs for functional cosmetics; regulation complies with the PMDA (Pharmaceuticals and Medical Devices Agency) for biomedical applications.
France	The EU REACH regulation in France is increasingly requiring COSMOS-standard certification for sericin-based organic cosmetics.
Italy	Italian businesses are subject to REACH, and sericin-containing skincare products need to be certified under European Organic Cosmetics.
Australia-New Zealand	Controlled under the AICIS (Australian Industrial Chemicals Introduction Scheme), chemical ingredients and cosmetic products need to be NICNAS- and New Zealand-EPA-compliant.

Industry Analysis

This industry will develop steadily until 2035, backed by increasing demand for natural and sustainable biomaterials for cosmetics, biomedical applications, and textile manufacturing. The main drivers are heightened consumer demand for sustainable products and supportive regulation in leading economies. New organic certification and green technology investments by manufacturers are poised to gain the most, while those depending on conventional chemical-intensive processes risk becoming uncompetitive players.

Top Strategic Imperatives, Risk Assessment, and Watchlist for Stakeholders

In preparation for future opportunities, stakeholders in this industry must channel their investment toward organic certification, green production technology, and diversification of the domestic industry. Establishing connections with cosmetic, biomedical, and textile technology innovators will allow companies to secure early-mover advantages, particularly in a future with growing demand for clean-label, sustainable ingredients. Fact.MR analysis indicates that compliance with international green certification programs like COSMOS and ECOCERT will increasingly be a powerful brand differentiator by 2025.

However, stakeholders must watch closely the regulatory tightening in Europe, the U.S., and areas in Asia, which may significantly raise compliance costs. Fact.MR is of the opinion that there are risks of supply chain breaks with unstable silk production volumes and higher labor costs in dominant sericulture areas like China and India, as per the FAO. Intellectual property protection remains a vulnerability, particularly in emerging industries in Asia, where counterfeit products will undermine brand value.

On the radar, stakeholders need to track burgeoning consumer demand for vegan biomaterials, novel biomedical uses of sericin, and government backing for bio-based industries, particularly in Europe and Japan, as per OECD. Early adoption of lab-based sericin extraction tech by early movers may counter raw material risk while opening up new revenue streams beyond traditional silk production.

For the Boardroom

To stay ahead, firms need to step up eco-innovation, intensify regional partnerships, and actively align with changing regulatory environments. Fact.MR research proposes that firms need to invest in sophisticated, eco-friendly extraction technologies at once and expedite collaborations with cosmetic and biomedical innovators to secure high-end industry niches.

Growth in the future will increasingly depend on obtaining organic and green certifications, especially in Europe, Japan, and Australia, where regulatory requirements are becoming more stringent. A plan should aim to expand into vegan and synthetic biology options for sericin, helping to reduce supply issues in traditional silk-producing countries.

Segment-Wise Analysis

By Form

Between 2025 and 2035, the solid form segment will be the most profitable due to its superior stability, longer shelf life, and increased consumer preference for solid formulations in personal care and cosmetics. As the demand for sustainable products and more efficient distribution channels increases, the solid form segment is likely to grow at a CAGR of around 7.6% between 2025 and 2035, slightly higher than the overall industry growth rate of 7.1%.

Solid products such as bars and tablets are simple to carry and convenient, which is in accordance with the changing consumer needs toward sustainable packaging and the environment. These considerations are especially attractive in regions such as North America and Europe, where environmental awareness is greater. Furthermore, solid formulations, generally perceived as more natural and using fewer preservatives, appeal to the growing clean beauty industry.

By Application

From 2025 to 2035, the personal care & cosmetics segment is projected to be the most profitable with the rising demand for clean, natural, and multifunctional products. The personal care & cosmetics segment is estimated to expand by around 8.2% CAGR through 2025 to 2035 and outgrow the industry's overall growth rate. As the consumer appetite for products that contain scientifically tested ingredients remains strong, it is increasing in popularity due to its favorable attributes in formulations for skin and hair care.

The increasing consciousness about skincare health, combined with the need for anti-aging and skin-repairing products, has rendered sericin a prime ingredient in high-end cosmetic products. Companies are adopting green practices, and sericin, a natural protein derived from silk, aligns perfectly with the clean beauty movement. Additionally, its moisturizing, anti-inflammatory, and skin-strengthening properties render it a highly desired ingredient in face creams, serums, and lotions.

Country-Wise Analysis

United States

Fact.MR predicts the industry in the U.S. to grow steadily at a CAGR of 5.2% during the period from 2025 to 2035. The U.S. industry is defined by high demand for sophisticated, technology-driven products in numerous industries. The movement towards sustainable and clean beauty and growing concern regarding health and wellness make the nation a driving force in innovation.

In addition, the regulatory requirements and the trend of increased transparency regarding product formulations are driving demand for quality ingredients at a faster rate. Major players in the U.S. are investing more in research and development to introduce new, effective treatments to the industry. As consumers gravitate towards personalized solutions, the U.S. industry can expect to gain from such changing consumer behaviors.

India

Fact.MR expects strong growth in this sector in India at a CAGR of 7.2% from 2025 to 2035. With a growing middle class and increasing disposable income, India offers a major opportunity for stakeholders. The rising trend of adopting modern beauty and healthcare trends, such as organic and natural ingredients, is in line with the global trend towards clean, sustainable products.

In addition, India's expanding e-commerce industry is making international products easily accessible, which is driving a larger industry footprint. The country's urbanization and rapid lifestyle shifts are also fueling demand. Moreover, government policies encouraging the domestic manufacture of ingredients and products, such as subsidies for the cosmetics industry, will help the industry grow in the next few years.

China

Fact.MR predicts the landscape in China will expand at a strong CAGR of 7.9% during the period 2025 to 2035. The rapidly changing consumer tastes in China, fueled by escalating awareness regarding personal health, wellness, and skin care, will drive this expansion. The escalation of disposable income, coupled with the growing middle class, is a key driver for the growth of the industry.

In addition, China's focus on research and development of the beauty and healthcare industries is fueling the uptake of innovative formulations and ingredients. With an increased need for luxury, high-end products, China is emerging as a center for premium beauty solutions. The regulatory landscape is also shifting, with the government promoting innovation while maintaining safety levels.

United Kingdom

Fact.MR projects that sales in the UK will rise by 5.5% during the period 2025 to 2035. The growth is mostly due to the high demand for ethical and environmentally friendly products, with growing interest in sustainability and ingredient transparency. British consumers are especially sensitive to clean beauty movements, leading to the uptake of natural and cruelty-free ingredients.

The UK's regulatory climate, which is strongly product safety and consumer protection oriented, also plays a role in the development of innovative, high-quality products. Moreover, the growth of influencer beauty trends and increased interest in wellness products also drive demand, making the UK a top industry in Europe.

Germany

Fact.MR anticipates that the industry in Germany will experience consistent growth, with a CAGR of 5.9% between 2025 and 2035. Germany's sericin industry has a high degree of consumer sophistication, especially within the healthcare and beauty industries. German consumers are increasingly buying products that appeal to the principles of sustainability and ethical sourcing.

The established manufacturing and research base of the country, as well as the strict quality standards, encourage innovation within the industry. The regulatory structure of the European Union also ensures that consumers only have access to the best products, which leads to trust in German brands. Furthermore, increasing demand for anti-aging, skin care, and wellness products will drive continued industry growth.

South Korea

Fact.MR forecasts that landscaping in South Korea will experience high growth in the industry, with a projected CAGR of 8.1% from 2025 to 2035. Renowned for its sophisticated beauty and skincare industry, South Korea boasts a strong culture of innovation, which is fueling industry demand for innovative products. With a growing health-conscious population and emphasis on skin care, South Korean consumers are eager to embrace new, science-based solutions.

The nation also has a robust export industry, with Korean beauty items becoming increasingly popular abroad. Technological advancements and new product development are further supported by government policies, which strengthen South Korea's leadership in the beauty and wellness industries.

Japan

Fact.MR anticipates the industry in Japan will grow with a CAGR of 6.0% during the 2025 to 2035 forecast period. Japan's industry is characterized by its desire for high-quality, efficient products, prioritizing precision and effectiveness. The aging population is a significant driver of demand, particularly for anti-aging and skin well-being products.

Additionally, Japan's innovative culture and technology have led to the development of extremely advanced beauty solutions that adapt to changing consumer requirements. Regulations in Japan are also very stringent, ensuring products in the industry have high levels of safety and effectiveness.

France

Fact.MR anticipates the sector in France will increase at a CAGR of 5.3% during the period from 2025 to 2035. As a global front-runner in the cosmetics sector, France is poised to retain its leading role in the beauty and healthcare industry on the back of a growing preference for natural, sustainable, and luxury goods.

French consumers have high standards for product effectiveness, which creates a focus on innovation. Furthermore, the nation's strong regulatory framework guarantees product safety, making France a priority industry for upscale beauty solutions. The constant migration toward clean beauty and green awareness among consumers further energizes the growth prospects for France's industry.

Italy

Fact.MR projects the industry in Italy will grow at a 6.3% CAGR over the forecast period of 2025 to 2035. The country's deep tradition in the luxury and fashion industries is shaping the beauty and personal care industry, and consumers here have a very high affinity for high-end products.

The industry is shifting toward sustainable and plant-based ingredients, keeping pace with worldwide trends in clean beauty. Italy's regulatory framework fosters innovation and upholds safety standards, rendering it appealing to both new entrants and established brands. The high demand for wellness and anti-aging products will continue to drive the growth of the industry.

Australia-New Zealand

Fact.MR projects that the landscape in Australia and New Zealand will grow at a CAGR of 7.0% during the period between 2025 and 2035. Both nations are witnessing a surge in consumers' interest in natural, organic, and sustainable products. The wellness and health trend is positively impacting the buying behavior, and the consumers are showing a greater inclination towards products that guarantee optimal, long-lasting results.

In addition, the increased consciousness of the environment has triggered a move toward green and cruelty-free beauty products. Australia and New Zealand's highly regulated industries guarantee high standards for product effectiveness and safety, further enhancing consumer confidence and fueling industry growth. The increased demand for individualized skincare products and anti-aging products will continue to propel the industry's upward growth pattern.

Competitive Landscape

The landscape is fairly fragmented, with a combination of global biotech companies, specialty chemical producers, and local suppliers. Although dominant players have considerable industry shares, the existence of niches and new producers promotes competition, especially in Asia-Pacific and other fast-growing industries.

Front-running companies are emphasizing environmentally friendly extraction techniques, product purity, and multiple applications as value differentiators. R&D expenditure on biomedical use, expansion in cosmetics and pharma, and tie-ups with healthcare and textile sectors are the key competitive approaches. Price competition, scale advantages in production, and compliance with regulatory standards are the key drivers for both industrial and premium segments.

Kraig Biocraft Laboratories, Inc. further developed its recombinant technology early in 2024 to meet medical and high-performance textile industry opportunities in Europe and North America. Seiren Co., Ltd. introduced a new ultra-purified formulation of sericin as an ingredient for cosmetics and skincare applications, capitalizing on growing interest in natural bioactive compounds.

Huzhou Xintiansi Bio-tech Co., Ltd. increased production capacity in China with cost-effective sericin extraction to enhance its foothold in the Asia-Pacific industry. Cocoon Biotech collaborated with European pharmaceutical firms to produce sericin-based wound-healing products, highlighting its biocompatibility and regenerative potential.

Competition Analysis

By 2025, Kraig Biocraft Laboratories, Inc., will dominate the industry with a 20-25% industry share in the recSericin technology-dominated industry and a strong presence in high-performance textile and biomedical applications, particularly in North American and European industries. Kraig Biocraft Laboratories' focus on scalable and green production will cement the company's grip during rising demand for green biomaterials.

Seiren Co., Ltd. (15-20%) will continue to maintain its premium status with emphasis on ultra-purified sericin for skin care and cosmetics due to its strong experience in silk-based proteins. The company will expand in APAC economies and Western economies by capitalizing on the expansion in demand for natural bioactive ingredients in the personal care and beauty segments.

Huzhou Xintiansi Bio-tech Co., Ltd. (10-15%) will strengthen its hold in the Asia-Pacific, with a focus on low-cost extraction and bulk production. Through its low prices and wide distribution channels, it will lead in textiles, medicines, and food additives.

Cocoon Biotech (8-12%) will grow in the medical and wound care space with the help of partnerships with European pharmaceutical firms to develop sericin-based regenerative medicines. Its focus on biocompatibility and tissue engineering will drive adoption in high-end healthcare use.

Sigma-Aldrich (Merck KGaA) (7-10%) will expand research-grade and pharma-grade sericin to academia and biotech companies. Its emphasis on high-purity uses and regulatory solutions will propel steady demand for drug delivery and biomedical studies. At the same time, Wuhan Healthful Biotechnology Co., Ltd. (5-8%) will address cost-sensitive customers with bulk-sale discounts to cosmetic manufacturers and nutraceutical companies, establishing its presence in the mass-industry segment with competitively priced sericin solutions.

Other Key Players

• DSM
• Hyundai Bioland
• Huzhou Xintiansi Bio-tech Co., Ltd
• Lanxess
• Rita Corporation
• Seiren Co.
• Specialty Natural Products Co. Ltd
• L'Oréal
• Estée Lauder
• Shiseido
• Amorepacific
• Beiersdorf
• Unilever
• Procter & Gamble
• Coty Inc.
• Johnson & Johnson
• Oriflame
• Revlon
• Mary Kay
• Natura & Co
• Kao Corporation
• Henkel

Segmentation

• By Form :

  • Solid
  • Liquid

• By Application :

  • Personal Care & Cosmetics
    • Hair Care
    • Skin Care
    • Others
  • Pharmaceuticals
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA